experts debate the pros and cons of treating subclinical hypothyroidism or hyperthyroidism

June 2012

You'll hear experts debate the pros and cons of treating subclinical hypothyroidism or hyperthyroidism.

There are good points on both sides.

Subclinical HYPOthyroidism is associated with an increased risk of ischemic heart disease, cardiovascular events, and mortality.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes a more "patient-centered" approach for choosing meds to add to metformin for type 2 diabetes
Lyme Disease questions about how to prevent or treat Lyme disease
Statins how to handle statin muscle pain
Neurology & Pain myths about ketorolac
Neurology & Pain warnings about codeine toxicity, especially in kids
Antithrombotics whether warfarin patients should get HIGHER loading doses and LESS frequent INR monitoring
STIs Veregen (VER-ah-jen, sinecatechins) as a new "natural" therapy for genital warts
Thyroid Disorders experts debate the pros and cons of treating subclinical hypothyroidism or hyperthyroidism
Bowel Preps Too many colonoscopy patients get an inadequate bowel prep
Geriatrics NEW Beers criteria for potentially inappropriate meds in patients 65 and over
Antibiotics whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death